Scholarlink

<p>The global demand for kidney replacement therapy (KRT) continues to increase, yet access remains limited in many low- and middle-income countries. Thailand has been recognized for integrating a sustainable KRT delivery model into its Universal Health Coverage scheme through a peritoneal dialysis–first (‘PD-First’) policy adopted in 2008. In 2022, the policy was revised to allow individuals to choose between hemodialysis or peritoneal dialysis as their first-line treatment. The intention was to improve patient choice and avoid high out-of-pocket costs, but the policy produced unintended consequences for the health system and patients. A Commission was convened to first assess the impact of the policy change and provide policy recommendations to the Thai government and, second, provide lessons for countries working to expand equitable access to KRT within national universal health coverage frameworks. Drawing on empirical data, the Commission—composed of Thai and international multidisciplinary experts—employed a structured deliberative process to inform policy interventions. The process and findings underscore the importance of participatory policymaking, underpinned by evidence and a systematic process, and monitoring and evaluation in managing complex policy transitions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Nature Medicine Commission on dialysis policy in low- and middle-income countries

  • 期刊论文

  • 发表日期：

    2026年1月21日

查看全文
  • Yot Teerawattananon,
  • Kinanti Khansa Chavarina,
  • Jeerath Phannajit,
  • Jiratorn Sutawong,
  • Natcha Yongphiphatwong,
  • Natasha Chawla,
  • Siobhan Botwright,
  • Tanainan Chuanchaiyakul,
  • Thunyarat Anothaisintawee,
  • Fatiu Arogundade,
  • Gloria Ashuntantang,
  • Jadej Thammatacharee,
  • Laura Sola,
  • Piyathida Chuengsaman,
  • Somsak Chunharas,
  • Suwit Wibulpolprasert,
  • Sydney C. W. Tang,
  • Talerngsak Kanjanabuch,
  • Valerie Luyckx,
  • Vuddhidej Ophascharoensuk,
  • Wanrudee Isaranuwatchai,
  • Vivekanand Jha,
  • Kearkiat Praditpornsilpa,
  • Kriang Tungsanga,
  • Chulathip Boonma,
  • Saudamini Vishwanath Dabak,
  • Chutidej Tabongkaraksa,
  • Kraiwiporn Kiattisunthorn,
  • Nipa Aiyasanon,
  • Netnapha Sitthitham,
  • Supakit Sirilak,
  • Thanapol Dokkaew,
  • Warangkana Pichaiwong,
  • Suwannee Sriprach,
  • Denla Pandejpong,
  • Dimple Haresh Butani,
  • Henny Aryani,
  • Jutamas Piyawong,
  • Kamol Khositrangsikun,
  • Kridsada Chareonrungruengchai,
  • Naline Gandhi,
  • Natanong Thamcharoen,
  • Nutthawongse Kiatkrissada,
  • Pitsinee Supapol,
  • Rujira Ngam-prukwanit,
  • Sajja Tatiyanupanwong,
  • Siriyakorn Khamkom,
  • Suchada Boonkaew,
  • Supichcha Thitjuea,
  • Wirun Limsawart,
  • Yot Teerawattananon

摘要

The global demand for kidney replacement therapy (KRT) continues to increase, yet access remains limited in many low- and middle-income countries. Thailand has been recognized for integrating a sustainable KRT delivery model into its Universal Health Coverage scheme through a peritoneal dialysis–first (‘PD-First’) policy adopted in 2008. In 2022, the policy was revised to allow individuals to choose between hemodialysis or peritoneal dialysis as their first-line treatment. The intention was to improve patient choice and avoid high out-of-pocket costs, but the policy produced unintended consequences for the health system and patients. A Commission was convened to first assess the impact of the policy change and provide policy recommendations to the Thai government and, second, provide lessons for countries working to expand equitable access to KRT within national universal health coverage frameworks. Drawing on empirical data, the Commission—composed of Thai and international multidisciplinary experts—employed a structured deliberative process to inform policy interventions. The process and findings underscore the importance of participatory policymaking, underpinned by evidence and a systematic process, and monitoring and evaluation in managing complex policy transitions.